News
Southwind Foods, a California-based company, "voluntarily" recalled a select amount of frozen shrimp due to possible ...
Bristol Myers leans on new launches to offset legacy drug declines, while GSK's diverse portfolio and strong HIV lineup keep growth on track.
10h
TipRanks on MSNBristol-Myers Squibb’s KarXT Study: A Potential Game-Changer in Schizophrenia Treatment
Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...
10h
TipRanks on MSNBristol-Myers Squibb’s Promising Study on Luspatercept for α-Thalassemia
Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...
NEW YORK – Krystal Biotech has discontinued a Phase I/II clinical trial evaluating an injected version of its gene therapy KB707 in locally advanced or metastatic solid tumors, including melanoma.
The FDA advises consumers not to eat the recalled products. Traces of Cesium-137 are widespread in the environment including ...
U.S. pharma bounced back in Q2, and in this episode of "The Top Line," Fierce Pharma's Eric Sagonowsky and Kevin Dunleavy ...
The Cleveland Clinic's Nathan Pennell, M.D., Ph.D., is switching to the Big Pharma realm to head up hematology and oncology ...
Malcolm Ethridge from Capital Area Planning Group sees potential in ServiceNow, Inc. despite recent dip. Bristol-Myers and ...
The FDA has updated its recall for frozen shrimp to include new grocery stores and states. Americans are being urged to check their freezers.
Bristol-Myers Squibb has been navigating some choppy waters but seems poised for a turnaround. Recently, shares have ticked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results